This comprehensive cancer monitoring profile tests for a range of tumour markers that are commonly associated with various types of cancer affecting women - including pancreatic cancer, colorectal cancer, breast cancer, ovarian cancer, colon cancer and liver cancer.
The use of tumour markers as screening tests is not established as tumour markers can be elevated in non-cancerous conditions and "normal" when cancer is present. These tests are intended to monitor the progression of an already diagnosed cancer or for recurrence of cancer following treatment.
Some tumour marker tests are thought to have value as a monitoring tool over time as any change in level can be acted upon quickly.
If you choose to have this test as a screening test then you should be aware of its limitations.
This is a test for women who wish to monitor their tumour marker levels following a diagnosis or treatment for cancer.
We send you an easy-to-use kit to collect your blood sample.
Post your sample to our lab in the prepaid envelope provided.
View results securely in your own personal dashboard.
Please see your doctor if you are suffering any unusual symptoms which persist - do not use these tests to self-diagnose. Tumour markers are most useful when viewed in conjunction with a clinical examination. Results do not constitute a diagnosis of cancer and markers are often tested to monitor treatment when cancer has already been diagnosed, or to check that it has not returned. Cancer markers can be elevated in benign conditions and results often produce false positives. Sometimes tumour markers can be normal even though cancer is present. Please make sure that you think carefully about the risks and benefits before taking this test.
Our tests are not a substitute for seeing your doctor, especially if you are suffering symptoms. Our doctors will interpret your results based on the information you have provided, but will not diagnose, consult or provide any treatment. You will be advised to see your doctor for any necessary follow-up action.
CA15-3 is a protein which is produced by a variety of cells, particularly breast cancer cells. It is primarily used as a marker to see how a patient is responding to breast cancer treatment or in monitoring for recurrence of the disease.
Raised levels can be seen in non cancerous conditions, such as pregnancy, endometriosis and liver damage, as well as in other cancers such as stomach, ovarian, pancreas and lung.
Alpha Feto Protein is a protein which is made by immature liver cells of the foetus. In adults it is a marker which is primarily used in the detection of liver cancer or cancer of the testes. It can also be raised in cancers of the stomach, bowel, lungs or breast.
Slighlty elevated levels can be seen in people with liver damage.
Carcino embryonic antigen (CEA) is a glycoprotein that is normally found in small amounts in the cells. In cases of cancer, predominantly bowel cancer but also breast, lung, pancreatic and stomach cancers, levels of CEA can be elevated. It is generally used to monitor an already diagnosed cancer or to check that cancer has not returned.
An elevated result is not necessarily diagnostic of cancer (CEA can also be raised in other non-malignant conditions) and it does not indicate where a cancer is located. However, an elevated result should be investigated, especially if symptoms are present.
Its use as a screening test is not established. Like other tests for tumour markers, a change in level over time may be more significant than the absolute level at a given point in time.
Cancer Antigen 125 (CA125) is a protein which is produced by cancer cells and which can be raised in cancers of the ovary, lung, breast, pancreas and gastrointestinal tract.
As CA125 is also produced by normal cells it is important to know your base level and monitor regularly so that any change can be picked up early.
A raised level is not necessarily a sign of cancer, just as a low level does not guarantee that cancer is not present. Elevated CA125 can be caused by anything that causes inflammation in the pelvic region including menstruation, endometriosis, pregnancy and pelvic inflammatory disease. However, we recommend that all raised levels are investigated further.
CA 19-9 (Pancreatic/Gut Antigen 19-9) is a tumour marker test which is mainly associated with pancreatic cancer and gastric cancer but can be raised in other cancers such as ovarian and liver cancer. Tumour markers can also be elevated in benign (non-cancerous) conditions and are not recommended as screening tests.
We will send you your Cancer Check (Female) blood sample collection kit together with the details of a convenient clinic where you can go and have your sample taken.
Your Cancer Check (Female) includes 1st class postage and packaging for you to send your blood sample directly to our laboratory for analysis. If you live in an area where you cannot rely on the post or you simply want to ensure that your sample arrives at the laboratory the following day, you may wish to send your blood sample guaranteed next day delivery for extra reassurance.
Your blood sample will be analysed at one of our chosen laboratories. You can be assured of fast, accurate results from one of our accredited independent providers of clinical diagnostic tests.
Our medical team will comment on out-of-range blood results and give you follow-up advice where necessary. If you need it, a PDF copy of your Cancer Check (Female) results can be downloaded for your doctor.
Once you have placed your order you will receive login details to mymedichecks.com where you can manage your account, track your orders and view your Cancer Check (Female) results.
Stay motivated by filling in your online health and lifestyle questionnaire and seeing how improvements in your lifestyle can influence your results. Your medical and family history gives us vital information when interpreting your results.